Kidtrayze

Zinc chloride, potassium iodide, sodium selenite, copper chloride dihydrate, and manganese chloride tetrahydrate, the active ingredients in Kidtrayze, are trace element supplements presented as an intravenous solution for parenteral use. They provide essential micronutrients to patients receiving total parenteral nutrition, helping to prevent or treat deficiencies that can impair enzymatic activity and metabolic processes.

GNH USA supplies Kidtrayze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Kidtrayze is used to supplement trace elements in patients receiving parenteral nutrition, addressing deficiencies that can affect enzymatic and metabolic functions. - Parenteral nutrition support: maintains adequate levels of zinc, iodine, selenium, copper and manganese in patients receiving total parenteral nutrition. - Critical illness or ICU care: helps prevent trace element depletion associated with severe illness and prolonged intravenous feeding. - Post‑surgical or transplant patients: supports recovery by providing essential micronutrients required for wound healing and immune function.

Kidtrayze may be associated with the following adverse reactions, which are reported in clinical use of trace element intravenous preparations.

Common Side Effects: - Injection site irritation: mild pain, redness, or swelling at the infusion site. - Transient metallic taste: brief metallic sensation in the mouth during or after infusion. - Mild nausea: occasional nausea without vomiting. - Headache: mild to moderate headache occurring shortly after administration.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Copper toxicity: signs include abdominal pain, liver enzyme elevation, or neurological symptoms. - Selenium excess (selenosis): manifested by hair loss, nail brittleness, or respiratory irritation. - Severe electrolyte imbalance: abnormal serum levels of trace elements leading to cardiac or neurological complications.

When using Kidtrayze, consider the following precautions to ensure safe administration and monitoring. - Renal impairment: monitor trace element levels and renal function closely. - Hepatic disease: adjust dosing and observe liver function tests. - Pregnancy and lactation: use only if clearly indicated after risk‑benefit assessment. - Known allergy to any component: avoid administration. - Compatibility: verify compatibility with other intravenous solutions before mixing. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidtrayze can interact with other medicines or nutrients; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Concurrent high‑dose copper supplements: risk of copper overload and toxicity. - High‑dose selenium preparations: may cause selenosis. - Iron dextran infusions: can precipitate trace elements, reducing efficacy.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., heparin): trace element imbalance may affect coagulation. - Loop diuretics: may alter electrolyte balance and trace element excretion. - Renal dialysis: can remove administered trace elements, diminishing therapeutic effect.